Table 4 Prevalence of fasting glucose ≥ 126 mg/dL and the proportion of ineffective glucose measurement (IGM) from 2003 to 2018 at China Medical University Hospital. The alphabet A to E represents the number of each condition and the proportion of each condition from B to E is derived from the ratio indicated in the brackets.
2003–2004 | 2005–2006 | 2007–2008 | 2009–2010 | 2011–2012 | 2013–2014 | 2015–2016 | 2017–2018 | |
|---|---|---|---|---|---|---|---|---|
(A) Number of patients with AContological | 61,066 | 61,730 | 75,105 | 88,008 | 100,581 | 111,988 | 141,614 | 151,371 |
(B) AContological ≥ 126 mg/dL, n (%) [B/A] | 17,353 (28.4) | 16,749 (27.1) | 17,842 (23.8) | 19,862 (22.6) | 22,832 (22.7) | 24,428 (21.8) | 27,131 (19.2) | 28,655 (18.9) |
(C) IGM, n (%) [C/B] | 4943 (28.5) | 4771 (28.5) | 5046 (28.3) | 5422 (27.3) | 6595 (28.9) | 6676 (27.3) | 7444 (27.4) | 7584 (26.5) |
(D) Algorithm-verified AC ≥ 126 mg/dL, n (%) [D/A] | 8607 (14.1) | 8458 (13.7) | 9073 (12.1) | 10,328 (11.7) | 11,456 (11.4) | 12,599 (11.3) | 13,938 (9.84) | 15,267 (10.1) |
(E) IGM, n (%) [E/D] | 4 (0.05) | 56 (0.66) | 38 (0.42) | 58 (0.56) | 56 (0.49) | 71 (0.56) | 74 (0.53) | 89 (0.58) |
